Clough Capital Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-77,359
| Closed | -$10.9M | – | 155 |
|
|
2017
Q3 | $10.9M | Sell |
77,359
-64,500
| -45% | -$9.05M | 0.73% | 44 |
|
|
2017
Q2 | $17.3M | Buy |
141,859
+17,159
| +14% | +$2.09M | 1.2% | 27 |
|
|
2017
Q1 | $15.1M | Buy |
124,700
+119,800
| +2,445% | +$14.5M | 0.96% | 33 |
|
|
2016
Q4 | $600K | Buy |
+4,900
| New | +$600K | 0.04% | 139 |
|
|
2016
Q2 | – | Sell |
-32,350
| Closed | -$4.5M | – | 251 |
|
|
2016
Q1 | $4.5M | Buy |
+32,350
| New | +$4.5M | 0.21% | 111 |
|
|
2015
Q3 | – | Sell |
-58,580
| Closed | -$10.6M | – | 231 |
|
|
2015
Q2 | $10.6M | Buy |
+58,580
| New | +$10.6M | 0.4% | 83 |
|